B. Deau

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Antoine Meyer

FRANCE

View details

Francesco Passamonti

ITALY

View details

Jan Novak

CZECH REPUBLIC

View details

antonio pagliuca

King's College London

UNITED KINGDOM

View details

David Sibon

Associate Professor, MD, PhD

Hôpitaux Universitaires Henri-Mondor

FRANCE

View details

Isabel Regalado-Artamendi

Instituto de Investigación Sanitaria Gregorio Marañón

SPAIN

View details

Laurent Dercle

Columbia University Irving Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

B. Deau

Research Interests

Explore related searches

Contact this professor

Articles (11)

Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA

Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA)

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.

Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study.

Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy.

Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice.

Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.

Collaborators (7)

Antoine Meyer

Francesco Passamonti

Jan Novak

antonio pagliuca

David Sibon

Isabel Regalado-Artamendi

Laurent Dercle

Make your next move.